MedPal AI (FRA:Z1N) Piotroski F-Score: 4 (As of Aug. 04, 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is MedPal AI Piotroski F-Score?

MedPal AI FRA:Z1N Piotroski F-Score is 4 as of Aug. 04, 2026, which is at its 10-year median of 4.00. The stock has 1 warning sign investors should review. Among 645 Healthcare Providers & Services companies, MedPal AI ranks worse than 66.82% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

MedPal AI has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for MedPal AI's Piotroski F-Score or its related term are showing as below:

FRA:Z1N' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 4   Max: 4
Current: 4

During the past 4 years, the highest Piotroski F-Score of MedPal AI was 4. The lowest was 3. And the median was 4.

MedPal AI  (FRA:Z1N) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


MedPal AI Piotroski F-Score Related Terms


MedPal AI Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for MedPal AI's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedPal AI Piotroski F-Score Chart

MedPal AI Annual Data
Trend Aug22 Aug23 Aug24 Aug25
Piotroski F-Score
N/A N/A 3.00 4.00

MedPal AI Semi-Annual Data
Aug22 Aug23 Feb24 Aug24 Feb25 Aug25 Feb26
Piotroski F-Score Get a 7-Day Free Trial 0.00 3.00 0.00 4.00 0.00

FRA:Z1N vs VEEV, BTSG, HQY: Piotroski F-Score Comparison

For the Health Information Services subindustry, MedPal AI's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedPal AI Piotroski F-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MedPal AI's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where MedPal AI's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Aug25) TTM:Last Year (Aug24) TTM:
Net Income was €-4.63 Mil.
Cash Flow from Operations was €-0.93 Mil.
Revenue was €0.00 Mil.
Gross Profit was €0.00 Mil.
Average Total Assets from the begining of this year (Aug24)
to the end of this year (Aug25) was (0.039 + 2.369) / 2 = €1.204 Mil.
Total Assets at the begining of this year (Aug24) was €0.04 Mil.
Long-Term Debt & Capital Lease Obligation was €0.00 Mil.
Total Current Assets was €2.07 Mil.
Total Current Liabilities was €0.76 Mil.
Net Income was €-0.02 Mil.

Revenue was €0.00 Mil.
Gross Profit was €0.00 Mil.
Average Total Assets from the begining of last year (Aug23)
to the end of last year (Aug24) was (0.035 + 0.039) / 2 = €0.037 Mil.
Total Assets at the begining of last year (Aug23) was €0.04 Mil.
Long-Term Debt & Capital Lease Obligation was €0.00 Mil.
Total Current Assets was €0.04 Mil.
Total Current Liabilities was €0.05 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

MedPal AI's current Net Income (TTM) was -4.63. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

MedPal AI's current Cash Flow from Operations (TTM) was -0.93. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Aug24)
=-4.627/0.039
=-118.64102564

ROA (Last Year)=Net Income/Total Assets (Aug23)
=-0.016/0.035
=-0.45714286

MedPal AI's return on assets of this year was -118.64102564. MedPal AI's return on assets of last year was -0.45714286. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

MedPal AI's current Net Income (TTM) was -4.63. MedPal AI's current Cash Flow from Operations (TTM) was -0.93. ==> -0.93 > -4.63 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Aug25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Aug24 to Aug25
=0/1.204
=0

Gearing (Last Year: Aug24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Aug23 to Aug24
=0/0.037
=0

MedPal AI's gearing of this year was 0. MedPal AI's gearing of last year was 0. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Aug25)=Total Current Assets/Total Current Liabilities
=2.072/0.763
=2.71559633

Current Ratio (Last Year: Aug24)=Total Current Assets/Total Current Liabilities
=0.039/0.053
=0.73584906

MedPal AI's current ratio of this year was 2.71559633. MedPal AI's current ratio of last year was 0.73584906. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

MedPal AI's number of shares in issue this year was 174.861. MedPal AI's number of shares in issue last year was 413.083. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=0/0
=

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=0/0
=

MedPal AI's gross margin of this year was . MedPal AI's gross margin of last year was . ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Aug24)
=0/0.039
=0

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Aug23)
=0/0.035
=0

MedPal AI's asset turnover of this year was 0. MedPal AI's asset turnover of last year was 0. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+1+1+1+0+0
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

MedPal AI has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 4 mean?
MedPal AI (FRA:Z1N) has a Piotroski F-Score of 4 as of Aug. 04, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on MedPal AI and its competitors. This is near median its historical median of 4.00. Over the past decade, MedPal AI's Piotroski F-Score has ranged from 3.00 to 4.00. According to the industry distribution chart, MedPal AI ranks #431 out of 645 companies in the Healthcare Providers & Services industry, placing it in the top 66.8%.
Is MedPal AI's Piotroski F-Score too high?
MedPal AI's current Piotroski F-Score of 4 is near median its 10-year median of 4.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 4.00. The Healthcare Providers & Services industry median Piotroski F-Score is 5.00. MedPal AI's value of 4 is 20% below this industry median. Based on the distribution chart, MedPal AI ranks #431 out of 645 companies in the Healthcare Providers & Services industry, which is below the industry midpoint.
How does MedPal AI's Piotroski F-Score compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, MedPal AI ranks #431 out of 645 companies for Piotroski F-Score. This places MedPal AI in the lower half of its industry. The industry median Piotroski F-Score is 5.00. MedPal AI's value of 4 is 20% below this benchmark. Historically, MedPal AI's own Piotroski F-Score has ranged from 3.00 to 4.00 over the past decade. While the company's 10-year median is 4.00 vs. the industry median of 5.00, MedPal AI has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Healthcare Providers & Services company?
The median Piotroski F-Score among Healthcare Providers & Services companies is 5.00, based on 645 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MedPal AI's current Piotroski F-Score of 4 is 20% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on MedPal AI and its competitors. For the Healthcare Providers & Services industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MedPal AI's current Piotroski F-Score is 4, which is near median its own 10-year median of 4.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedPal AI stock overvalued right now?
MedPal AI (FRA:Z1N) has a current Piotroski F-Score of 4. The current Piotroski F-Score is 4, which is near median its 10-year median of 4.00 and 20% below the Healthcare Providers & Services industry median of 5.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For MedPal AI (FRA:Z1N), the current Piotroski F-Score is 4 as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MedPal AI Business Description

Other Exchanges MPAL:UK
Address 71 Queen Victoria Street, Floor 8, London, GBR, EC4V 4AY
MedPal AI PLC is a UK-based digital health and artificial intelligence company focused on the development and commercialisation of AI-enabled healthcare platforms.. Its platform aggregates data across devices and apps (including Apple Health, Fitbit, Garmin, and Google Fit) to deliver real-time, personalized health insights. The Company has two reportable segments, Software and Corporate.